Trials / Completed
CompletedNCT02716909
Pessary in Singleton Gestations With Short Cervix Without Prior Preterm Birth
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 300 (actual)
- Sponsor
- Federico II University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Spontaneous preterm birth (SPTB) remains the number one cause of perinatal mortality in many countries, including the United States. In singleton gestations a short cervical length (CL) on transvaginal ultrasound (TVU) has been shown to be a good predictor of SPTB. The cervical pessary is a silicone device that has been used to prevent SPTB. The efficacy of cervical pessary has been assessed in several populations including singletons with short CL, unselected twins, twins with a short CL, and triplet pregnancies. Several randomized clinical trials (RCTs) have been published, and several are ongoing. However, no consensus on the use of cervical pessary in pregnancy or guidelines for management have been assessed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cervical pessary | The cervical pessary is a silicone device that has been used to prevent SPTB Pessary will be placed between 18 and 23 6/7 weeks gestation, and will be removed during the 37th week of pregnancy (or earlier, if indicated) |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2017-05-01
- Completion
- 2017-07-01
- First posted
- 2016-03-23
- Last updated
- 2018-06-18
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT02716909. Inclusion in this directory is not an endorsement.